BACLOFEN
- Product NDC
- 17856-0319
- 11-digit product format
- 178560319
- Labeler code
- 17856
- Product ID
- 17856-0319_ef25a8cc-ed04-4b0b-8e88-5bf746761136
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BACLOFEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- ANDA209102
- Marketing category
- ANDA
- Marketing start
- 2018-04-01
- Marketing end
- 0000-00-00
- Substance
- BACLOFEN
- Active strength
- 5 mg/1
- Pharmacologic classes
- GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 17856-0319 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 17856-0319 | 17856-0319-1 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209102-001 | BACLOFEN | BACLOFEN | 5MG | TABLET / ORAL | AB | 2017-11-28 | |
| A209102-002 | BACLOFEN | BACLOFEN | 10MG | TABLET / ORAL | AB | 2017-11-28 | |
| A209102-003 | BACLOFEN | BACLOFEN | 20MG | TABLET / ORAL | AB | 2017-11-28 | |
| A209102-004 | BACLOFEN | BACLOFEN | 15MG | TABLET / ORAL | AB | 2024-02-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209102-001 | AB |
| A209102-002 | AB |
| A209102-003 | AB |
| A209102-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209102-001 | BACLOFEN | 5MG | TABLET / ORAL | AB | 2017-11-28 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209102-002 | BACLOFEN | 10MG | TABLET / ORAL | AB | 2017-11-28 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209102-003 | BACLOFEN | 20MG | TABLET / ORAL | AB | 2017-11-28 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209102-004 | BACLOFEN | 15MG | TABLET / ORAL | AB | 2024-02-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209102-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209102-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209102-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209102-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BACLOFEN | BACLOFEN | Redpharm Drug | 53df4b4b-842e-9e3a-e063-6394a90a8a3d | 2026-06-10 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | REMEDYREPACK INC. | e017a001-8cb1-4dd8-960e-c6d74005f57f | 2026-05-12 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | REMEDYREPACK INC. | ac9b720f-b755-49f1-9850-efb26feadaeb | 2026-04-14 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | PD-Rx Pharmaceuticals, Inc. | ee59a379-17d5-487f-b72f-a53e74744a70 | 2026-03-27 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | PD-Rx Pharmaceuticals, Inc. | 91175128-8285-4d04-89a9-219781be9260 | 2026-03-25 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | PD-Rx Pharmaceuticals, Inc. | 16266972-843e-4ea5-be1f-fb1b1588a5dc | 2026-03-25 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | PD-Rx Pharmaceuticals, Inc. | 0a1d09ac-94d5-45ef-92cc-bc261c2b2d75 | 2026-03-25 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Major Pharmaceuticals | 46f84504-ffc4-4be5-9598-c20a3f4210f4 | 2026-02-13 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Advagen Pharma Limited | 04dac0f6-cc6c-4959-9bca-a6e4a99690f3 | 2026-01-23 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | REMEDYREPACK INC. | 00c6c924-ddfd-4a75-afd7-f6561ff9abbc | 2026-01-21 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Advanced Rx of Tennessee, LLC | 459ec5f5-4f99-e917-e063-6294a90a23cd | 2025-12-18 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | SOLA Pharmaceuticals, LLC | 7b308b35-8c08-458d-860e-c78d057e8260 | 2025-12-08 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Proficient Rx LP | 0680301a-1649-46c4-b74e-ab03967945d0 | 2025-12-01 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | PD-Rx Pharmaceuticals, Inc. | 5cba5255-e5ad-48fd-8385-60e9ea6b6407 | 2025-10-09 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | REMEDYREPACK INC. | 4e2cd27d-91c7-4f15-96cc-3971769dbeaa | 2025-10-01 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Asclemed USA, Inc. | 35bccefe-8d2e-85b5-e063-6394a90a58ca | 2025-08-13 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | A-S Medication Solutions | eb690a49-b87b-433f-9afe-2966406fe00e | 2025-07-15 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | A-S Medication Solutions | af0ade6c-9dd4-42d3-879e-4201fbe585ee | 2025-07-15 | Warnings, Adverse reactions | 209102 ANDA209102 |
| BACLOFEN | BACLOFEN | Proficient Rx LP | 0243dd97-1d40-48f7-8853-76e046c605f2 | 2025-04-01 | Warnings, Adverse reactions | 209102 ANDA209102 |
| Baclofen | BACLOFEN | Direct_Rx | 020632f4-5e8a-f4a0-e063-6294a90a6301 | 2025-01-28 | Warnings, Adverse reactions | 209102 ANDA209102 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e25d01b-2e92-4765-bec7-8a0fd7bdc346 | Product name | 2 | 20251208 |
| 1b1393e5-f2d8-42f5-a070-e3416d619667 | Product name | 1 | 20250804 |
| 88583480-702d-4dfe-a31c-9c00abd818f8 | Product name | 7 | 20250729 |
| 1cf3c538-592e-4b4b-869e-51d4bf3ca83d | Product name | 2 | 20240703 |
| 6e532d1f-e0b5-46eb-a2be-d70bd338df9d | Product name | 1 | 20220613 |
| ef6bc0bf-8134-f06b-70d9-4980df6f808e | Product name | 5 | 20210615 |
| eeec0918-7a2f-44bf-83d6-1216e507adbf | Product name | 3 | 20191217 |
| a5300adb-f538-4abb-a49e-f8f0b8d9ac75 | Product name | 1 | 20190611 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0319-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-c4fa-0266-e053-dadaa90a7c1a | BACLOFEN TABLETS, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0319-1 | BACLOFEN | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 1 | |
| 17856-0319-1 | BACLOFEN | 1 in 1 POUCH | TABLET | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0319 | BACLOFEN TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Legacy NDC, 2 package rows | 20210514_9760d274-fe1c-49a4-bc68-eff8142b75ec.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 430902 | baclofen 5 MG Oral Tablet | PSN | 9760d274-fe1c-49a4-bc68-eff8142b75ec | 1 |
| 430902 | baclofen 5 MG Oral Tablet | SCD | 9760d274-fe1c-49a4-bc68-eff8142b75ec | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 17856-0319-1 | 17856031901 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0319-1) > 1 TABLET in 1 POUCH | 100 pouch | 2021-05-12 | 0000-00-00 | No | No | Current |